Osaka, Japan

Katsuichi Sudo

This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuichi Sudo. Retrieved from https://idiyas.com/inventor/katsuichi-sudo-w7xsuqef

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuichi Sudo: Innovator in Ophthalmic Preparations

Introduction

Katsuichi Sudo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development. His work focuses on creating effective solutions for eye-related conditions, particularly in the area of corneal health.

Latest Patents

Katsuichi Sudo holds a patent for a corneal opacification inhibitory composition. This ophthalmic preparation comprises a fumagillol derivative that is designed to inhibit corneal opacification occurring after ophthalmic surgery. The patent details a complex chemical formula that includes various hydrocarbon and heterocyclic groups, showcasing Sudo's expertise in medicinal chemistry.

Career Highlights

Sudo is associated with Senju Pharmaceutical Co., Ltd., a company known for its commitment to developing innovative pharmaceutical products. His work at Senju has allowed him to focus on advancing ophthalmic treatments and improving patient outcomes.

Collaborations

Throughout his career, Katsuichi Sudo has collaborated with esteemed colleagues such as Yasuko Umegaki and Yasushi Okumura. These partnerships have contributed to the success of his research and the development of new therapeutic options in ophthalmology.

Conclusion

Katsuichi Sudo's contributions to the field of ophthalmology through his innovative patent demonstrate his commitment to improving eye health. His work continues to influence the development of effective treatments for corneal conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…